Systematic review for the 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Hypertension. Jun 2018; 71(6):e116-e135. PMID: 29133355. 58. Wright JT, Jr., Williamson JD, Whelton PK, et al. A randomized trial of intensive versus standard blood-pressure control. N Engl J Med. Nov 26 2015;373(22):2103-2116. PMID: 26551272. 59. Brunstrom M, Eliasson M, Nilsson PM, Carlberg B. Blood pressure treatment levels and choice of antihypertensive agent in people with diabetes mellitus: An overview of systematic reviews. J Hypertens. Mar 2017;35(3):453-462. PMID: 27870655. 60. Katsanos AH, Filippatou A, Manios E, et al. Blood pressure reduction and secondary stroke prevention: A systematic review and metaregression analysis of randomized clinical trials. Hypertension. Jan 2017;69(1): 171-179. PMID: 27802419. 61. Zonneveld TP, Richard E, Vergouwen MD, et al. Blood pressure-lowering treatment for preventing recurrent stroke, major vascular events, and dementia in patients with a history of stroke or transient ischaemic attack. Cochrane Database Syst Rev. Jul 19 2018;7:Cd007858. PMID: 30024023. 62. Sink KM, Evans GW, Shorr RI, et al. Syncope, hypotension, and falls in the treatment of hypertension: Results from the randomized clinical Systolic Blood Pressure Intervention Trial. J Am Geriatr Soc. Apr 2018;66(4): 679-686. PMID: 29601076. 63. Tinetti ME, McAvay GJ, Fried TR, et al. Health outcome priorities among competing cardiovascular, fall injury, and medication-related symptom outcomes. Journal of the American Geriatrics Society. 2008;56(8):1409-1416. PMID: 18662210. 64. SHEP Cooperative Research Group. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). SHEP cooperative research group. Jama. Jun 26 1991;265(24):3255-3264. PMID: 2046107. 65. Staessen JA, Fagard R, Thijs L, et al. Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. The systolic hypertension in Europe (Syst-Eur) trial investigators. Lancet. Sep 13 1997;350(9080):757-764. PMID: 9297994. 66. UK Prospective Diabetes Study Group. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. BMJ. 1998;317(7160):703-713. 67. O'Connor PJ, Narayan KM, Anderson R, et al. Effect of intensive versus standard blood pressure control on depression and health-related quality of life in type 2 diabetes: The ACCORD trial. Diabetes Care. Jul 2012; 35(7):1479-1481. PMID: 22584134. 68. Patel A, MacMahon S, Chalmers J, et al. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med. Jun 12 2008;358(24):2560-2572. PMID: 18539916. 69. Veterans Administration Cooperative Study Group on Antihypertensive Agents. Effects of treatment on morbidity in hypertension. Results in patients with diastolic blood pressures averaging 115 through 129 mm hg. Jama. Dec 11 1967;202(11):1028-1034. PMID: 4862069. 70. Veterans Administration Cooperative Study Group on Antihypertensive Agents. Effects morbidity of treatment on in hypertension: II. Results in patients with diastolic blood pressure averaging 90 through 114 mm hg. JAMA. 1970;213(7):1143-1152. 71. Hypertension Detection and Follow-Up Program Cooperative Group. Five-year findings of the hypertension detection and follow-up program. I. Reduction in mortality of persons with high blood pressure, including mild hypertension. Hypertension Detection and Follow-up Program Cooperative Group. Jama. Dec 7 1979;242(23): 2562-2571. PMID: 490882. 72. Hypertension Detection and Follow-up Program Cooperative Group. The effect of treatment on mortality in mild hypertension. New England Journal of Medicine. 1982;307(16):976-980. PMID: 7110301. 73. MRC Working Party. MRC trial of treatment of mild hypertension: Principal results. Medical Research Council Working Party. Br Med J (Clin Res Ed). Jul 13 1985;291(6488):97-104. PMID: 2861880. 74. Beddhu S, Chertow GM, Cheung AK, et al. Influence of baseline diastolic blood pressure on effects of intensive compared with standard blood pressure control. Circulation. Jan 9 2018;137(2):134-143. PMID: 29021322. 75. Greer N, Bolduc J, Geurkink E, et al. Pharmacist-led chronic disease management: A systematic review of effectiveness and harms compared with usual care. Ann Intern Med. Apr 26 2016. PMID: 27111098. 76. Santschi V, Chiolero A, Colosimo AL, et al. Improving blood pressure control through pharmacist interventions: A meta-analysis of randomized controlled trials. J Am Heart Assoc. Apr 10 2014;3(2):e000718. PMID: 24721801. 77. Bosworth HB, Olsen MK, McCant F, et al. Telemedicine cardiovascular risk reduction in veterans: The CITIES trial. Am Heart J. May 2018;199:122-129. PMID: 29754649. 78. Cheema E, Sutcliffe P, Weickert MO, Singer DRJ. A randomised controlled trial of the impact of structured written and verbal advice by community pharmacists on improving hypertension education and control in patients with high blood pressure. Eur J Clin Pharmacol. Nov 2018;74(11):1391-1395. PMID: 30022334. 79. Margolis KL, Asche SE, Dehmer SP, et al. Long-term outcomes of the effects of home blood pressure telemonitoring and pharmacist management on blood pressure among adults with uncontrolled hypertension: Follow-up of a cluster randomized clinical trial. JAMA Netw Open. Sep 7 2018;1(5):e181617. PMID: 30646139. 80. Victor RG, Blyler CA, Li N, et al. Sustainability of blood pressure reduction in black barbershops. Circulation. Jan 2 2019;139(1):10-19. PMID: 30592662. 81. Amer M, Rahman N, Nazir SR, et al. Impact of pharmacist's intervention on disease related knowledge, medication adherence, HRQoL and control of blood pressure among hypertensive patients. Pak J Pharm Sci. Nov 2018;31(6 (Supplementary):2607-2616. PMID: 30587468. 82. Zhu X, Wong FKY, Wu CLH. Development and evaluation of a nurse-led hypertension management model: A randomized controlled trial. Int J Nurs Stud. Jan 2018;77:171-178. PMID: 29100199. 83. Persell SD, Karmali KN, Lazar D, et al. Effect of electronic health record-based medication support and nurse- led medication therapy management on hypertension and medication self-management: A randomized clinical trial. JAMA Intern Med. Aug 1 2018;178(8):1069-1077. PMID: 29987324. 84. Ogedegbe G, Plange-Rhule J, Gyamfi J, et al. Health insurance coverage with or without a nurse-led task shifting strategy for hypertension control: A pragmatic cluster randomized trial in Ghana. PLoS Med. May 2018;15(5):e1002561. PMID: 29715303. 85. Sarfo F, Treiber F, Gebregziabher M, et al. PINGS (phone-based intervention under nurse guidance after stroke): Interim results of a pilot randomized controlled trial. Stroke. Jan 2018;49(1):236-239. PMID: 29222227. 86. Sarfo FS, Treiber F, Gebregziabher M, et al. Phone-based intervention for blood pressure control among Ghanaian stroke survivors: A pilot randomized controlled trial. Int J Stroke. Nov 22 2018:1747493018816423. PMID: 30465630. 87. Bolarinwa OA, Juni MH, Nor Afiah MZ, Salmiah MS, Akande TM. Mid-term impact of home-based follow-up care on health-related quality of life of hypertensive patients at a teaching hospital in Ilorin, Nigeria. Niger J Clin Pract. Jan 2019;22(1):69-78. PMID: 30666023. 88. Parappilly BP, Field TS, Mortenson WB, Sakakibara BM, Eng JJ. Effectiveness of interventions involving nurses in secondary stroke prevention: A systematic review and meta-analysis. Eur J Cardiovasc Nurs. Dec 2018; 17(8):728-736. PMID: 29856237. 89. Riegel GR, Ribeiro PAB, Rodrigues MP, Zuchinali P, Moreira LB. Efficacy of nutritional recommendations given by registered dietitians compared to other healthcare providers in reducing arterial blood pressure: Systematic review and meta-analysis. Clin Nutr. Apr 2018;37(2):522-531. PMID: 28065482. 90. World Health Organization. Mhelath: New horizons for health through mobile technologies. Global Observatory for eHealth. 7 June 2011 2011;3. 91. Liu S, Brooks D, Thomas SG, Eysenbach G, Nolan RP. Effectiveness of user- and expert-driven web-based hypertension programs: An rct. Am J Prev Med. Apr 2018;54(4):576-583. PMID: 29456025. 92. Nolan RP, Feldman R, Dawes M, et al. Randomized controlled trial of e-counseling for hypertension: REACH. Circ Cardiovasc Qual Outcomes. Jul 2018;11(7):e004420. PMID: 30006474. 93. Alessa T, Abdi S, Hawley MS, de Witte L. Mobile apps to support the self-management of hypertension: Systematic review of effectiveness, usability, and user satisfaction. JMIR Mhealth Uhealth. Jul 23 2018;6(7): e10723. PMID: 30037787. 94. Xiong S, Berkhouse H, Schooler M, et al. Effectiveness of mhealth interventions in improving medication adherence among people with hypertension: A systematic review. Curr Hypertens Rep. Aug 7 2018;20(10):86. PMID: 30088110. 95. Marquez Contreras E, Marquez Rivero S, Rodriguez Garcia E, et al. Specific hypertension smartphone app to improve medication adherence in hypertension: A cluster-randomized trial. Curr Med Res Opin. Nov 15 2018: 1-15. PMID: 30431384. 96. McLean G, Murray E, Band R, et al. Digital interventions to promote self-management in adults with hypertension: Protocol for Systematic review and meta-analysis. JMIR Res Protoc. Nov 20 2015;4(4):e133. PMID: 26589728. 97. Luo L, Ye M, Tan J, et al. Telehealth for the management of blood pressure in patients with chronic kidney disease: A systematic review. Journal of Telemedicine and Telecare. 2019;25(2):80-92. PMID: 29172929. 98. Vargas G, Cajita MI, Whitehouse E, Han HR. Use of short messaging service for hypertension management: A systematic review. J Cardiovasc Nurs. May/Jun 2017;32(3):260-270. PMID: 27111819. 99. Chen T-Y, Kao C-W, Cheng S-M, Chang Y-C. Effect of home medication titration on blood pressure control in patients with hypertension: A Meta-Analysis of randomized controlled trials. Medical care. 2019;57(3): 230-236. PMID: 30762831. 100. Beishuizen CR, Stephan BC, van Gool WA, et al. Web-based interventions targeting cardiovascular risk factors in middle-aged and older people: A systematic review and meta-analysis. J Med Internet Res. Mar 11 2016; 18(3):e55. PMID: 26968879. 101. Pan F, Wu H, Liu C, et al. Effects of home telemonitoring on the control of high blood pressure: A randomised control trial in the fangzhuang community health center, beijing. Aust J Prim Health. Nov 2018;24(5):398-403. PMID: 30131099. 102. Seetharamaiah S, Tantia O, Goyal G, et al. LSG vs OAGB 1 year follow-up data a randomized control trial. Obesity surgery. 2017;27(4):948-954. 103. Siebenhofer A, Jeitler K, Horvath K, et al. Long-term effects of weight-reducing drugs in people with hypertension. Cochrane Database Syst Rev. Mar 2 2016;3:Cd007654. PMID: 26934640. 104. Schiavon CA, Bersch-Ferreira AC, Santucci EV, et al. Effects of bariatric surgery in obese patients with hypertension: The GATEWAY Randomized Trial (gastric bypass to treat obese patients with steady hypertension). Circulation. Mar 13 2018;137(11):1132-1142. PMID: 29133606. 105. Yan Y, Sha Y, Yao G, et al. Roux-en-y gastric bypass versus medical treatment for type 2 diabetes mellitus in obese patients: A systematic review and meta-analysis of randomized controlled trials. Medicine (Baltimore). Apr 2016;95(17):e3462. PMID: 27124041. 106. Tay J, Luscombe-Marsh ND, Thompson CH, et al. A very low-carbohydrate, low-saturated fat diet for type 2 diabetes management: A randomized trial. Diabetes Care. Nov 2014;37(11):2909-2918. PMID: 25071075. 107. Kucharska A, Gajewska D, Kiedrowski M, et al. The impact of individualised nutritional therapy according to DASH diet on blood pressure, body mass, and selected biochemical parameters in overweight/obese patients with primary arterial hypertension: A prospective randomised study. Kardiol Pol. 2018;76(1):158-165. PMID: 28980293. 108. Semlitsch T, Jeitler K, Berghold A, et al. Long-term effects of weight-reducing diets in people with hypertension. Cochrane Database Syst Rev. Mar 2 2016;3:Cd008274. PMID: 26934541. 109. Zhang X, Devlin HM, Smith B, et al. Effect of lifestyle interventions on cardiovascular risk factors among adults without impaired glucose tolerance or diabetes: A systematic review and meta-analysis. PLoS One. 2017; 12(5):e0176436. PMID: 28493887. 110. Whelton PK, Appel LJ, Espeland MA, et al. Sodium reduction and weight loss in the treatment of hypertension in older persons: A randomized controlled trial of nonpharmacologic interventions in the elderly (TONE). TONE Collaborative Research Group. Jama. Mar 18 1998;279(11):839-846. PMID: 9515998. 111. Herrod PJJ, Doleman B, Blackwell JEM, et al. Exercise and other nonpharmacological strategies to reduce blood pressure in older adults: A systematic review and meta-analysis. J Am Soc Hypertens. Apr 2018;12(4):248-267. PMID: 29496468. 112. Corso LM, Macdonald HV, Johnson BT, et al. Is concurrent training efficacious antihypertensive therapy? A meta-analysis. Med Sci Sports Exerc. Dec 2016;48(12):2398-2406. PMID: 27471784. 113. Maruf FA, Akinpelu AO, Salako BL, Akinyemi JO. Effects of aerobic dance training on blood pressure in individuals with uncontrolled hypertension on two antihypertensive drugs: A randomized clinical trial. J Am Soc Hypertens. Apr 2016;10(4):336-345. PMID: 26948962. 114. Bellissimo MP, Galaviz KI, Paskert MC, Lobelo F. Cardiometabolic risk reduction through recreational group sport interventions in adults: A systematic review and meta-analysis. Mayo Clin Proc. Oct 2018;93(10): 1375-1396. PMID: 30139702. 115. Reichert T, Costa RR, Barroso BM, da Rocha VdMB, Delevatti RS, Kruel LFM. Aquatic training in upright position as an alternative to improve blood pressure in adults and elderly: A systematic review and meta-analysis. Sports medicine (Auckland, N.Z.). 2018/07// 2018;48(7):1727-1737. PMID: 29651756. 116. Chan AWK, Chair SY, Lee DTF, et al. Tai chi exercise is more effective than brisk walking in reducing cardiovascular disease risk factors among adults with hypertension: A randomised controlled trial. Int J Nurs Stud. Dec 2018;88:44-52. PMID: 30195124. 117. Ma C, Zhou W, Tang Q, Huang S. The impact of group-based tai chi on health-status outcomes among community-dwelling older adults with hypertension. Heart Lung. Jul - Aug 2018;47(4):337-344. PMID: 29778251. 118. Yang H, Wu X, Wang M. The effect of three different meditation exercises on hypertension: A network meta- analysis. Evid Based Complement Alternat Med. 2017;2017:9784271. PMID: 28529532. 119. Wu Y, Johnson BT, Acabchuk RL, et al. Yoga as antihypertensive lifestyle therapy: A systematic review and meta-analysis. Mayo Clin Proc. Mar 2019;94(3):432-446. PMID: 30792067. 120. Kelley GA, Kelley KA, Tran ZV. Aerobic exercise and resting blood pressure: A meta-analytic review of randomized, controlled trials. Preventive cardiology. 2001;4(2):73-80. PMID: 11828203. 121. Whelton SP, Chin A, Xin X, He J. Effect of aerobic exercise on blood pressure: A meta-analysis of randomized, controlled trials. Ann Intern Med. Apr 2 2002;136(7):493-503. PMID: 11926784. 122. Sacks FM, Obarzanek E, Windhauser MM, et al. Rationale and design of the Dietary Approaches to Stop Hypertension trial (DASH). A multicenter controlled-feeding study of dietary patterns to lower blood pressure. Ann Epidemiol. Mar 1995;5(2):108-118. PMID: 7795829. 123. Appel LJ, Moore TJ, Obarzanek E, et al. A clinical trial of the effects of dietary patterns on blood pressure. DASH Collaborative Research Group. N Engl J Med. Apr 17 1997;336(16):1117-1124. PMID: 9099655. 124. Vollmer WM, Sacks FM, Ard J, et al. Effects of diet and sodium intake on blood pressure: Subgroup analysis of the DASH-sodium trial. Ann Intern Med. Dec 18 2001;135(12):1019-1028. PMID: 11747380. 125. Institute of Medicine. Dietary reference intakes for water, potassium, sodium, chloride, and sulfate. 2005. 126. Sacks FM, Svetkey LP, Vollmer WM, et al. Effects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension (DASH) diet. DASH-Sodium Collaborative Research Group. N Engl J Med. Jan 4 2001;344(1):3-10. PMID: 11136953. 127. Cook NR, Cutler JA, Obarzanek E, et al. Long term effects of dietary sodium reduction on cardiovascular disease outcomes: Observational follow-up of the Trials of Hypertension Prevention (TOHP). Bmj. Apr 28 2007; 334(7599):885-888. PMID: 17449506. 128. Kumanyika SK, Cook NR, Cutler JA, et al. Sodium reduction for hypertension prevention in overweight adults: Further results from the Trials of Hypertension Prevention Phase II. J Hum Hypertens. Jan 2005;19(1):33-45. PMID: 15372064. 129. Shea MK, Nicklas BJ, Houston DK, et al. The effect of intentional weight loss on all-cause mortality in older adults: Results of a randomized controlled weight-loss trial. Am J Clin Nutr. Sep 2011;94(3):839-846. PMID: 21775558. 130. U.S. Department of Health and Human Services and U.S. Department of Agriculture. 2015 2020 dietary guidelines for americans. 2015. 131. Quader ZS ZL, Gillespie C, et al. Sodium intake among persons aged 2 years United States, 2013 2014. MMWR Morb Mortal Wkly Rep. 2017 66(12):324-238. 132. Toledo E, Hu FB, Estruch R, et al. Effect of the Mediterranean diet on blood pressure in the PREDIMED trial: Results from a randomized controlled trial. BMC Med. Sep 19 2013;11:207. PMID: 24050803. 133. Estruch R, Ros E, Salas-Salvado J, et al. Primary prevention of cardiovascular disease with a Mediterranean diet. N Engl J Med. Apr 4 2013;368(14):1279-1290. PMID: 23432189. 134. Estruch R, Ros E, Salas-Salvado J, et al. Primary prevention of cardiovascular disease with a Mediterranean diet supplemented with extra-virgin olive oil or nuts. N Engl J Med. Jun 21 2018;378(25):e34. PMID: 29897866. 135. Thomopoulos C, Parati G, Zanchetti A. Effects of blood pressure-lowering on outcome incidence in hypertension: 5. Head-to-head comparisons of various classes of antihypertensive drugs - overview and meta- analyses. J Hypertens. Jul 2015;33(7):1321-1341. PMID: 26039526. 136. Wright JT, Jr., Dunn JK, Cutler JA, et al. Outcomes in hypertensive black and nonblack patients treated with chlorthalidone, amlodipine, and lisinopril. Jama. Apr 6 2005;293(13):1595-1608. PMID: 15811979. 137. ALLHAT Collaborative Research Group. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack trial (ALLHAT). JAMA. Dec 18 2002;288(23):2981-2997. PMID: 12479763. 138. Leenen FH, Nwachuku CE, Black HR, et al. Clinical events in high-risk hypertensive patients randomly assigned to calcium channel blocker versus angiotensin-converting enzyme inhibitor in the antihypertensive and lipid- lowering treatment to prevent heart attack trial. Hypertension. Sep 2006;48(3):374-384. PMID: 16864749. 139. Julius S, Alderman MH, Beevers G, et al. Cardiovascular risk reduction in hypertensive black patients with left ventricular hypertrophy: The LIFE study. J Am Coll Cardiol. Mar 17 2004;43(6):1047-1055. PMID: 15028365. 140. Agodoa LY, Appel L, Bakris GL, et al. Effect of ramipril vs amlodipine on renal outcomes in hypertensive nephrosclerosis: A randomized controlled trial. Jama. Jun 6 2001;285(21):2719-2728. PMID: 11386927. 141. Rahman M, Ford CE, Cutler JA, et al. Long-term renal and cardiovascular outcomes in Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack trial (ALLHAT) participants by baseline estimated GFR. Clin J Am Soc Nephrol. Jun 2012;7(6):989-1002. PMID: 22490878. 142. Thomopoulos C, Parati G, Zanchetti A. Effects of blood pressure-lowering treatment on cardiovascular outcomes and mortality: 14 - effects of different classes of antihypertensive drugs in older and younger patients: Overview and meta-analysis. J Hypertens. Aug 2018;36(8):1637-1647. PMID: 29847487. 143. Beckett NS, Peters R, Fletcher AE, et al. Treatment of hypertension in patients 80 years of age or older. N Engl J Med. 2008;358(18):1887-1898. PMID: 18378519. 144. Jamerson K, Weber MA, Bakris GL, et al. Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients. N Engl J Med. Dec 4 2008;359(23):2417-2428. PMID: 19052124. 145. Fried LF, Emanuele N, Zhang JH, et al. Combined angiotensin inhibition for the treatment of diabetic nephropathy. N Engl J Med. Nov 14 2013;369(20):1892-1903. PMID: 24206457. 146. Parving HH, Brenner BM, McMurray JJ, et al. Cardiorenal end points in a trial of aliskiren for type 2 diabetes. N Engl J Med. Dec 6 2012;367(23):2204-2213. PMID: 23121378. 147. Yusuf S, Teo KK, Pogue J, et al. Telmisartan, ramipril, or both in patients at high risk for vascular events. N Engl J Med. Apr 10 2008;358(15):1547-1559. PMID: 18378520. 148. Cushman WC, Ford CE, Einhorn PT, et al. Blood pressure control by drug group in the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack trial (ALLHAT). J Clin Hypertens (Greenwich). Oct 2008; 10(10):751-760. PMID: 19090876. 149. Salam A, Kanukula R, Atkins E, et al. Efficacy and safety of dual combination therapy of blood pressure- lowering drugs as initial treatment for hypertension: A systematic review and meta-analysis of randomized controlled trials. J Hypertens. Sep 2019;37(9):1768-1774. PMID: 30986788. 150. Liu L, Xu B, Ju Y. Addition of spironolactone in patients with resistant hypertension: A meta-analysis of randomized controlled trials. Clin Exp Hypertens. 2017;39(3):257-263. PMID: 28448185. 151. Wang C, Xiong B, Huang J. Efficacy and safety of spironolactone in patients with resistant hypertension: A meta-analysis of randomised controlled trials. Heart Lung Circ. Oct 2016;25(10):1021-1030. PMID: 27118266. 152. Makai P, IntHout J, Deinum J, Jenniskens K, Wilt GJV. A network meta-analysis of clinical management strategies for treatment-resistant hypertension: Making optimal use of the evidence. J Gen Intern Med. Aug 2017;32(8):921-930. PMID: 28275946. 153. Williams B, MacDonald TM, Morant SV, et al. Endocrine and haemodynamic changes in resistant hypertension, and blood pressure responses to spironolactone or amiloride: The PATHWAY-2 mechanisms substudies. Lancet Diabetes Endocrinol. Jun 2018;6(6):464-475. PMID: 29655877. 154. Krieger EM, Drager LF, Giorgi DMA, et al. Spironolactone versus clonidine as a fourth-drug therapy for resistant hypertension: The ReHOT randomized study (Resistant Hypertension Optimal Treatment). Hypertension. Apr 2018;71(4):681-690. PMID: 29463627. 155. Rossignol P, Claggett BL, Liu J, et al. Spironolactone and resistant hypertension in heart failure with preserved ejection fraction. Am J Hypertens. Mar 10 2018;31(4):407-414. PMID: 29228101. 156. Agency for Health Research and Quality. The effective health care program stakeholder guide appendix d: Research questions & PICO(TS) 2011. https://www.ahrq.gov/research/findings/evidence-based- reports/stakeholderguide/appendixc.html. 157. Guyatt GH, Oxman AD, Kunz R, et al. GRADE guidelines: 2. Framing the question and deciding on important outcomes. J Clin Epidemiol. Apr 2011;64(4):395-400. PMID: 21194891. 158. Andrews J, Guyatt G, Oxman AD, et al. GRADE guidelines: 14. Going from evidence to recommendations: The significance and presentation of recommendations. J Clin Epidemiol. Jul 2013;66(7):719-725. PMID: 23312392. 159. National Heart Lung and Blood Institute. Your guide to lowering your blood pressure with DASH: DASH eating plan: Lower your blood pressure. Bethesda, Md. U.S. Dept. of Health and Human Services, National Institutes of Health, National Heart, Lung, and Blood Institute; 2006. 160. Martinez-Gonzalez MA, Corella D, Salas-Salvado J, et al. Cohort profile: Design and methods of the PREDIMED study. Int J Epidemiol. Apr 2012;41(2):377-385. PMID: 21172932.